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Objective: To determine whether quantitative perfusion parameters of dynamic contrast-enhanced magnetic resonance 
imaging (DCE-MRI) correlate with immunohistochemical markers of angiogenesis in rectal cancer. 
Materials and Methods: Preoperative DCE-MRI was performed in 63 patients with rectal adenocarcinoma. Transendothelial 
volume transfer (Ktrans) and fractional volume of the extravascular-extracellular space (Ve) were measured by Interactive 
Data Language software in rectal cancer. After surgery, microvessel density (MVD) and vascular endothelial growth factor 
(VEGF) expression scores were determined using immunohistochemical staining of rectal cancer specimens. Perfusion 
parameters (Ktrans, Ve) of DCE-MRI in rectal cancer were found to be correlated with MVD and VEGF expression scores by 
Spearman’s rank coefficient analysis. T stage and N stage (negative or positive) were correlated with perfusion parameters 
and MVD.
Results: Significant correlation was not found between any DCE-MRI perfusion parameters and MVD (rs = -0.056 and p = 
0.662 for Ktrans; rs = -0.103 and p = 0.416 for Ve), or between any DCE-MRI perfusion parameters and the VEGF expression 
score (rs = -0.042, p = 0.741 for Ktrans; r = 0.086, p = 0.497 for Ve) in rectal cancer. TN stage showed no significant 
correlation with perfusion parameters or MVD (p > 0.05 for all).
Conclusion: DCE-MRI perfusion parameters, Ktrans and Ve, correlated poorly with MVD and VEGF expression scores in rectal 
cancer, suggesting that these parameters do not simply denote static histological vascular properties.
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INTRODUCTION
Tumor angiogenesis is essential for tumor growth and 
progression (1). In colorectal cancer, angiogenesis is 
associated with transmural extension as well as with 
lymphatic and distant hematogenous metastases (2). Tumor 
angiogenesis activity may be evaluated by direct or indirect 
methods. The direct method has been considered the 
standard for assessment. It measures immunohistochemical 
markers such as microvessel density (MVD) and vascular 
endothelial growth factor (VEGF) expression. However, the 
direct method is invasive, time consuming and difficult 
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patients (39 men and 24 women; mean age, 61 years [range, 
36-88 years]) were included in this study.
MR Imaging and Protocols
MRI examination was performed on a 3.0 tesla scanner 
(MAGNETOM TrioTim; Siemens, Erlangen, Germany) applying 
a 6-element body phased-array coil on the anterior side 
of the patient and another 6-element spine coil on the 
posterior side. Patients underwent bowel preparation 
including intravenous injection of a 20-mg dose of 
scopolamine butylbromide (Buscopan, Boehringer Ingelheim 
Korea, Seoul, Korea) and luminal distension with 80-100 
mL of sonography transmission gel (Progel®, Dayo, Seoul, 
Korea) using an enema syringe before the MRI examination. 
Axial, sagittal, and oblique T2-weighted MR images were 
obtained using a respiratory-triggered turbo spin-echo 
sequence for anatomical imaging.
Dynamic contrast-enhanced magnetic resonance imaging 
was performed using a free-breathing T1-weighted three-
dimensional (3D) spoiled gradient echo fat low-angle shot 
(FLASH) sequence with fat suppression on the axial plane. 
The protocol for the T1 map included a T1-weighted spin 
echo pulse sequence with 16 slices, TE of 8.5 msec, and 
three different TRs of 100, 400 and 1000 msec. Dynamic 
T1-weighted images were obtained with the following 
parameter settings: TE/TR of 1.18/3.58, flip angle of 
20°, temporal resolution of 1.5-1.6 seconds, total of 341 
dynamic images per slice, total imaging time of 8 minutes 
48 seconds, single acquisition with parallel acquisition 
(generalized autocalibrating partially parallel acquisitions, 
acceleration factor 2), and the same field of view and 
matrix as those of the T1 map protocol. A bolus injection of 
gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) 
at a dosage of 0.1 mmoL/kg (Magnevist, Schering, Berlin, 
Germany) was followed by 10 pre-acquisitions. Contrast 
agent was injected at 2 mL/second using a power injector 
with a chasing bolus of 20 mL normal saline. The MRI 
with which to achieve reproducible results. For these 
reasons, dynamic contrast-enhanced magnetic resonance 
imaging (DCE-MRI) has now become a promising indirect 
method with high spatial resolution and no associated 
radiation hazards (3-5). Some investigators have reported 
the usefulness of DCE-MRI in rectal cancer, mostly in 
terms of therapeutic monitoring after chemotherapy 
and radiotherapy (6-9). Only few reports have evaluated 
the relationship between DCE-MRI perfusion parameters 
and histological markers of angiogenesis and have 
shown conflicting results (10-12). These reports used 
relatively small sample sizes using an 1.5T MR scanner 
or semiquantitative parameters on the basis of time- 
intensity curves. Therefore, the purpose of our study was to 
investigate whether quantitative perfusion parameters of 
DCE-MRI, specifically transendothelial volume transfer (Ktrans) 
and fractional volume of the extravascular-extracellular 
space (Ve), correlate with immunohistochemical markers of 
angiogenesis in rectal cancer when determined using a high 
field 3.0T scanner with high temporal resolution.
MATERIALS AND METHODS
Patient Population
This retrospective study was approved by our institutional 
review board and a waiver of informed consent was 
obtained. Patients with histologically proven primary 
rectal adenocarcinoma who had received treatment 
were included in this study. The patients underwent 
elective primary surgical resection within 2 weeks of 
their staging MRI examination. DCE-MRI sequence was 
routinely performed as part of our pre-operative rectal MR 
protocol. From September 2008 to April 2009, a total of 
72 patients were enrolled. However, nine patients were 
excluded because of small tumor volumes that were not 
detectable on MR imaging (n = 5) or procedural failures for 
immunohistochemical staining (n = 4). Finally, a total of 63 
Table 1. 3.0-T MR Imaging Sequences and Parameters
Parameter T2-2D TSE T2-2D TSE T2-2D TSE T2-2D TSE T1-3D FLASH
Plane Sagittal Axial Oblique axial Oblique coronal Axial
Repetition time (ms) 5310 3800 3800 3800 3.58
Echo time (ms) 113 98 98 98 1.08
Matrix 320 x 320 448 x 314 448 x 314 448 x 314 384 x 378
Section thickness/slice spacing (mm) 3/0 5/2 3/0 3/0 5/0
Echo train length 35 17 17 17 -
Field of view (mm) 250 x 250 239 x 239 199 x 199 199 x 199 320 x 260
Note.— TSE = turbo spin echo, FLASH = fast low angle shot, 3D = three dimensional
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sequence parameters used are detailed in Table 1.
Imaging Analysis
Analysis of the DCE-MRI data was based on the 
generalized kinetic model by Tofts and Kermode (13, 
14). According to this model after bolus injection of 
contrast agent at dose D given at time t = 0, the plasma 
concentration of contrast agent decays biexponentially: 
a1 and a2 are the amplitudes of the components, and m1 and 
m2 are their decay rate constants. In humans, amplitudes a1 
= 3.99 kg/liter and a2 = 4.78 kg/liter, and rate constants m1 
= 0.144 min-1 and m2 = 0.0111 min-1, according to the data 
of Weinmann et al (16). In this study, the dose D of Gd-
DTPA was 0.1 mmoL/kg body weight. This model predicts 
changes in the concentration of contrast agent in the tissue 
due to its transfer between plasma and interstitial space: 
Ktrans is the volume transfer constant between blood plasma 
and extravascular extracellular space (EES), and Ve is the 
EES fractional volume, which is the volume of EES per unit 
volume of tissue. To obtain the volume transfer constant 
Ktrans, a concentration curve was fitted to the above Tofts 
and Kermode model at pixel resolution. 
All in-house software for pharmacokinetic modeling was 
written in Interactive Data Language (Interactive Data 
Language, Research Systems, Boulder, CO, USA). MR images 
were analyzed by an experienced gastrointestinal radiologist 
who was blinded to the pathologic data. Regions of interest 
(ROIs) were manually contoured along the edge of the 
tumor on dynamic T1-weighted FLASH images, section by 
section in thicknesses of 5 mm on the central three levels of 
the tumor and referenced on the corresponding T2-weghted 
axial images. The mean summed sizes of three serial ROIs in 
the tumor and normal rectal wall were 11.13 ± 6.45 cm2 and 
3.63 ± 1.92 cm2, respectively. The mean Ktrans and Ve of all 
voxels within each ROI were derived. The radiologist drew 
three ROIs for each tumor and normal rectal wall twice, and 
average values for the perfusion parameters (Ktrans and Ve) 
were calculated. 
Immunohistochemical Staining and Quantification  
of Histologic Parameters
In addition to routine tissue sampling for pathologic 
staging, additional tissue blocks from each tumor were 
acquired for immunohistochemical staining by the 
pathologist. The pathologist was attentive to the fact that 
the histological assessment involved specimens obtained 
at a tumor level in which the largest transverse diameter 
was detected on MRI. Tissue blocks from each patient were 
stained immunohistochemically for CD34 and VEGF. The 
pathologist evaluated the MVD and VEGF expression scores 
while being blinded to the DCE-MRI findings. To determine 
MVD, three tumor “hotspots” [highly vascularized areas 
within the tumor; Weidner counting method (18)] were 
identified at low magnification, and the highest number of 
microvessels in each were counted at 200 x magnification. 
The MVD score was expressed as the mean number of 
microvessels per 1 mm2. VEGF staining was assessed using 
staining intensity (1, no; 2, weak; 3, moderate; and 4, 
strong staining), and the percentage of tumor area was 
stained at 200 x magnification (1, < 5; 2, 5-20; 3, 21-50; 
and 4, > 50%). The sum of these two scores was the VEGF 
expression score, ranging from 2 to 8 (19).
Statistical Analysis
Statistical analyses were performed using statistics 
software (SAS v 9.2, SAS Institute, Cary, NC, USA; MedCalc, 
version 9.3.6.0, MedCalc Soft ware, Mariakerke, Belgium). 
Mean values with standard deviations were calculated for all 
parameters. Perfusion MRI parameters for rectal cancer wall 
were compared with those from the normal rectal wall using 
the paired t test. Perfusion parameters of rectal cancer were 
correlated with the MVD and VEGF expression scores using 
Spearman’s rank coefficient analysis. Perfusion parameters 
and MVD were also correlated with T stage (1, 2, 3, or 4) 
and N stage (negative or positive) using the generalized 
linear regression procedure and one-way analysis of 
variance. P values less than 0.05 were considered to 
indicate statistically significant differences.
RESULTS
All 63 patients underwent radical surgery for 
pathologically confirmed rectal adenocarcinoma: Mile’s 
operation in 4 patients, low anterior resection in 51 
patients, and ultra low anterior resection in 8 patients. 
The mean tumor size was 4.5 cm (range, 2-12 cm). The 
Cp = D (a1e-m1t + a2e-m2t) (15)
Ct = D·Ktrans ∑ ai
i = 1, 2
exp(-Ktrans t/Ve) - exp (-mit)
mi - Ktrans /Ve
(17)
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types of the tumors found in the patients were 19 upper, 
38 middle, and 6 lower third tumors. Histopathological 
tumor staging was determined to be T1 in 5, T2 in 10, T3 
in 41, and T4 in 7 patients. Thirty-three patients had lymph 
node metastases. The tumor was well-differentiated in 4, 
moderately-differentiated in 58, and poorly-differentiated 
in 1 patient. The mean summed Ktrans and Ve values of the 
three serial ROIs were 1.824 ± 0.909 (range, 0.456-4.423) 
min-1 and 0.424 ± 0.229 (range, 0.121-0.902), respectively, 
for the tumor, and 0.600 ± 0.443 (range, 0.078-1.248) min-1 
and 0.416 ± 0.284 (range, 0.057-0.857), respectively, in the 
normal rectal wall. The mean Ktrans was significantly higher 
in rectal cancer than in the normal rectal wall (p < 0.0001), 
but the mean Ve was not significantly different (p = 0.570).
Correlation between Perfusion Parameters and 
Immunohistochemical Markers of Tumor Angiogenesis 
The average hot-spot MVD score of rectal cancer 
specimens was 81.9 ± 32.8 (range: 27.7-231.1), and the 
average VEGF expression score was 7.0 ± 0.7 (range: 5.0-
8.0). Table 2 shows the correlation between MRI perfusion 
parameters and immunohistochemical markers of tumor 
angiogenesis. No significant correlations were found 
between MRI perfusion parameters (Ktrans and Ve) and the 
MVD or VEGF expression score (Figs. 1, 2).
Correlation between Perfusion Parameters and TN Stage 
in Rectal Cancer
There was no significant correlation between MRI 
perfusion parameters (Ktrans and Ve) and T stage or N 
stage (Table 3). MRI perfusion parameters were also not 
significantly different between the hot-spot MVD score, T 
stage or N stage.
DISCUSSION
To obtain nutrients for growth and to metastasize to 
other organs, a tumor develops both structurally and 
functionally abnormal new vasculature that is leaky with 
a hazard pattern of interconnections (20, 21). This leads 
to higher endothelial permeability and blood flow within 
the tumor, and thereby increases the Ktrans value. Published 
studies have reported that the Ktrans value in rectal cancer 
wall is significantly higher compared with the normal rectal 
wall or muscle tissue (12, 22). In our study, DCE-MRI of 
rectal cancer also revealed a significantly higher Ktrans value 
compared to the value of the normal rectal wall. However, 
the Ve values did not significantly differ between tumor 
and normal wall in our study. Ve is defined as the fractional 
volume of the EES. The EES and vascular space are balanced 
for adequate nutrient and oxygen supply in normal tissues, 
but the balance is disrupted in tumors. In most tumors, 
the EES is enlarged and differs depending on the tumor 
type and aggressiveness (23). DCE-MRI has been used 
in an attempt to quantify the EES of tumors and normal 
tissues (14, 24, 25). Published studies regarding rectal 
cancer have revealed conflicting results, with some results 
showing significantly higher Ve values on DCE-MRI (12) and 
others showing similar Ve values (22) on perfusion CT for 
rectal cancer wall versus the normal rectal wall or muscle 
tissue, respectively. Janssen et al. (22) presumed that the 
relatively short imaging time may create a bias resulting in 
similar Ve values for tumor and normal tissues. The absence 
of a significant difference in Ve in our study is difficult to 
explain, because our imaging time (8 minutes 48 seconds) 
was sufficient. The physiological microenvironment of the 
tumor is heterogeneous, and the ESS is related to several 
parameters of the tumor microenvironment such as cell 
density, hypoxic fraction or interstitial fluid pressure, thus 
causing Ve values to be variable (25). 
There have been published reports on the use of DCE-MRI 
as an indirect method for assessing angiogenesis in rectal 
cancer, and these reports have shown varying results (10-12, 
26). Atkin et al. (10) reported that there was no correlation 
between tumor markers of angiogenesis and kinetic MRI 
parameters. However, other investigators reported that 
DCE-MRI parameters showed a significant correlation with 
MVD (11, 12, 26) and VEGF expression (11). Yao et al. (12) 
suggested that Ktrans correlated positively with TNM staging 
and Dukes staging.
Table 2. Correlation between Perfusion Parameters and Immunohistochemical Markers of Angiogenesis in Rectal Cancer 
MRI Parameter
Hot-Spot MVD (No. of Vessels/mm2) VEGF Expression Score
rs P-Value rs P-Value
Ktrans (min-1) -0.056 0.662 -0.042 0.741
Ve -0.103 0.416 0.086 0.497
Note.— P values were determined using Spearman’s rank coefficient (rs) analysis. no = number, MVD = microvessel density, VEGF = 
vascular endothelial growth factor
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Fig. 1. Dynamic contrast-enhanced magnetic resonance imaging image of pathologically T2N0 rectal cancer from 50-year-old woman.
Three serial ROIs were drawn from three sections through tumor (A), and mean Ktrans (1.174 min-1) and Ve (0.209) were obtained (B). 
Histopathologic specimen of rectal adenocarcinoma showed (C) high MVD score (vascular endothelial cells shown in brown identify microvessels) 
and (D) strong VEGF expression (positive expression of VEGF is shown in brown in cytoplasm; 100 x). Hot-spot MVD was 99.3 (mean number of 
microvessel/mm2), and VEGF expression score was 7. ROI = region of interest, MVD = microvessel density, VEGF = vascular endothelial growth 
factor
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Fig. 2. Scattergram shows relationship between Ktrans and MVD score (A) and between Ktrans and VEGF score (B). Ktrans value is not 
correlated with MVD and VEGF scores. MVD = microvessel density, VEGF = vascular endothelial growth factor
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In our study, there was no direct correlation 
between MRI perfusion parameters (Ktrans and Ve) and 
immunohistochemical markers of tumor angiogenesis 
(MVD score and VEGF expression score). For the detailed 
evaluation of MRI perfusion parameters, we analyzed 
specimens according to T and N stage. There was no 
significant difference in MRI perfusion parameters when 
values were grouped by T or N stage. The MVD scores 
was also not significantly different when the values were 
grouped by T or N stage. In this regard, our study is 
concordant with the report described above by Atkin et al. 
(10). Although we used the highest temporal resolution 
(1.5-1.6 seconds) in 3D DCE-MR imaging and had the largest 
sample size (n = 63) ever reported in colorectal cancer (10-
12, 26), the results of our study do not support the general 
trend that DCE-MRI parameters directly reflect tumor 
angiogenesis. The lack of correlation between perfusion 
parameters with MVD and VEGF expression may reflect the 
wide variation in the functional status of tumor vasculature. 
A tumor typically has structurally and functionally abnormal 
new vasculature, which is leaky, tortuous and dilated 
(21). MVD is a measurement of vessel density, whereas 
DCE-MRI reflects the functional status of only perfused 
tumor vessels and reflects physiological variables such 
as tumor blood flow and capillary permeability (3). A 
histopathology-MR imaging correlation may not be seen 
because of the discrepancy between the anatomical and 
the functional status of the tumor vasculature. Similarly, 
tumor VEGF measurements reflect only static data, thus the 
lack of correlation between VEGF and DCE-MRI parameters 
according to the dynamic local microenvironmental changes 
of the tumor (10, 27). 
It is possible that MVD and VEGF may not accurately 
reflect tumor angiogenesis. Hlatky et al. (28) reported that 
MVD reflects the metabolic burden of the supported tumor 
cells rather than angiogenic dependence. Previous studies 
reported that VEGF expression in endometrial carcinoma (29) 
and lung cancer (30) was not correlated with microvessel 
count. Although VEGF is an important component in 
angiogenesis (31, 32), the process of angiogenesis may 
depend on the net balance of many positive angiogenic 
factores, such as VEGF, fibroblast growth factors, epidermal 
growth factor, transforming growth factors, thymidine 
phosphorylase and negative angiogenic factors, such as 
thrombospondin and angiostatin (33). Because of the 
complexity of the angiogenic process, it is unlikely that any 
single specific indicator is responsible for the process (33).
One of the major limitations of this study was that the 
pathological tissue sections from which MVD and VEGF 
estimates were determined were not necessarily taken 
from the same MRI planes. Tumor shape can change and 
shrinkage can occur during tissue processing after surgery. 
Furthermore, the comparison between DCE-MRI parameters 
measured at the millimeter level versus histological markers 
at the micrometer level (34) may be additional limitations. 
Another limitation is that we did not obtain perfusion 
parameters for the entire tumor volume. ROI analysis is 
prone to bias and may not adequately represent tumor 
heterogeneity. To minimize these limitations, ROIs were 
drawn from three sections through the tumor, and the mean 
Ktrans and Ve values were obtained in our study.
In conclusion, DCE-MRI perfusion parameters (Ktrans and 
Ve) are less likely to show a direct correlation with the MVD 
and VEGF expression scores in rectal cancer.
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